| Adenosine 2B receptor expression on cancer cells promotes metastasis D Mittal, D Sinha, D Barkauskas, A Young, M Kalimutho, K Stannard, ... Cancer research 76 (15), 4372-4382, 2016 | 159 | 2016 |
| Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis J Jeffery, D Sinha, S Srihari, M Kalimutho, KK Khanna Oncogene 35 (6), 683-690, 2016 | 135 | 2016 |
| Mitotic slippage: an old tale with a new twist D Sinha, PHG Duijf, KK Khanna Cell cycle 18 (1), 7-15, 2019 | 106 | 2019 |
| Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer PV Raninga, AC Lee, D Sinha, YY Shih, D Mittal, A Makhale, AL Bain, ... International journal of cancer 146 (1), 123-136, 2020 | 70 | 2020 |
| CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer M Kalimutho, D Sinha, J Jeffery, K Nones, S Srihari, WC Fernando, ... EMBO molecular medicine 10 (9), e8566, 2018 | 70 | 2018 |
| Cep55 overexpression causes male‐specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling D Sinha, M Kalimutho, J Bowles, AL Chan, DJ Merriner, AL Bain, ... The FASEB Journal 32 (9), 4984-4999, 2018 | 50 | 2018 |
| Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition PV Raninga, A Lee, D Sinha, L Dong, KK Datta, X Lu, P Kalita-de Croft, ... Theranostics 10 (12), 5259, 2020 | 43 | 2020 |
| Enhanced dependency of KRAS‐mutant colorectal cancer cells on RAD 51‐dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae M Kalimutho, AL Bain, B Mukherjee, P Nag, DM Nanayakkara, SK Harten, ... Molecular oncology 11 (5), 470-490, 2017 | 37 | 2017 |
| Prophylactic and therapeutic strategies for Epstein–Barr Virus-associated diseases: emerging strategies for clinical development V Desari, D Sinha, MA Neller, C Smith, R Khanna Expert reviews on vaccines 18 (5), 457-474, 2019 | 33 | 2019 |
| Cep55 overexpression promotes genomic instability and tumorigenesis in mice D Sinha, P Nag, D Nanayakkara, PHG Duijf, A Burgess, P Raninga, ... Communications biology 3 (1), 593, 2020 | 27 | 2020 |
| Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer M Kalimutho, D Sinha, D Mittal, S Srihari, D Nanayakkara, S Shafique, ... Journal of Experimental & Clinical Cancer Research 38, 1-18, 2019 | 17 | 2019 |
| Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras CGP Doss, S Debottam, C Debajyoti Protoplasma 250, 787-792, 2013 | 17 | 2013 |
| 'Off-the-shelf’allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies D Sinha, S Srihari, K Beckett, L Le Texier, M Solomon, A Panikkar, ... Journal for ImmunoTherapy of Cancer 9 (2), 2021 | 13 | 2021 |
| Pretransplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study M Altaf, KE Lineburg, P Crooks, S Rehan, KK Matthews, MA Neller, ... The Journal of infectious diseases 224 (2), 312-317, 2021 | 12 | 2021 |
| Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine CGP Doss, C Debajyoti, S Debottam Cell biochemistry and biophysics 67, 1075-1079, 2013 | 10 | 2013 |
| Studies on the dielectric properties of natural urinary stones D Sinha, K Anwar, K Kumari, S Jaishwal, S Madeshwaran, S Keshari, ... Advanced Materials Research 584, 484-488, 2012 | 8 | 2012 |
| The impact of gold nanoparticles on hTERT gene expression leading to termination of malignant tumor CGP Doss, C Debajyoti, S Debottam Gene 493 (1), 140-141, 2012 | 8 | 2012 |
| Joining forces: improving clinical response to cellular immunotherapies with small-molecule inhibitors D Sinha, C Smith, R Khanna Trends in Molecular Medicine 27 (1), 75-90, 2021 | 7 | 2021 |
| Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients S Das, A Babu, T Medha, G Ramanathan, AG Mukherjee, UR Wanjari, ... Medical Oncology 40 (5), 149, 2023 | 5 | 2023 |
| Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis B Rashidieh, B Shohayeb, AL Bain, PRJ Fortuna, D Sinha, A Burgess, ... PLoS genetics 17 (10), e1009334, 2021 | 4 | 2021 |
deepak mittalSenior Research OfficerVerified email at qimr.edu.au
